In this study, we analyzed three independent pan-cancer datasets and revealed that the association of IDH1 mutation with TP53 alteration is specific to glioma, which indicates a tissue-specific role for TP53 alteration in gliomagenesis. Here, TP53 is linked to central nervous system cancer.